The global treatment-resistant hypertension management market is set to witness substantial growth in the coming years, according to forecasts released by FMI. Projections indicate a significant expansion from USD 43 million in 2023 to a staggering USD 159.41 million by 2033. This impressive surge reflects a compound annual growth rate (CAGR) of 14%, marking a …
Tag Archives: Treatment-Resistant Hypertension Management Market
Global Treatment-Resistant Hypertension Management Market Set to Reach US$ 159.41 Million by 2033
The global treatment-resistant hypertension management market is poised for substantial growth, with forecasts predicting an expansion from US$ 43 million in 2023 to US$ 159.41 million by 2033. This impressive increase represents a compound annual growth rate (CAGR) of 14%, reflecting a notable acceleration from the 11% CAGR recorded between 2018 and 2022. Treatment-resistant hypertension …
Surging Ahead: Treatment-Resistant Hypertension Management Market Progressive Path to Better Patient Outcomes with a 14% CAGR Envisioned till 2033, FMI Investigates
The Treatment-Resistant Hypertension Management Market is a medical condition characterized by persistently high blood pressure despite the use of three or more antihypertensive medications. TRH poses a significant challenge to both patients and healthcare providers, as it increases the risk of cardiovascular events and end-organ damage. Consequently, the market for TRH management has witnessed a …